CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to harness ultrasound technology to control drug and protein activity in a biocompatible manner. By developing ultrasound-sensitive carriers, it seeks to improve therapies for conditions like cancer and diabetes through precise drug delivery.
To date, light has been employed as a widespread trigger to achieve control over the activity of drugs and protein function establishing the fields of photopharmacology and optogenetics, respectively.
Both techniques led to promising new therapies, the elucidation of brain function or understanding of neural disorders.
However, serious limitations resulting from the low penetration depth of light into tissues are severely hampering progress in these fields.
In contrast to photons, ultrasound dee…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
